Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application

Cancer Research

Volumn 66, Issue 17, 2006, Pages 8822-8828

  Pong, Rey Chen ^a   Roark, Ryan ^a   Ou, Jiun Yih ^a   Fan, Jianhai ^a   Stanfield, Jennifer ^a   Frenkel, Eugene ^a   Sagalowsky, Arthur ^a   Hsieh, Jer Tsong ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; FR 901228; GENISTEIN; HISTONE DEACETYLASE INHIBITOR; IPRIFLAVONE; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN;

ACETYLATION; ADENOVIRUS; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVITY; ENZYME REPRESSION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SOYBEAN;

ADENOVIRIDAE; CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; ENTEROVIRUS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HISTONE DEACETYLASES; HUMANS; PHYTOESTROGENS; PROMOTER REGIONS (GENETICS); RECEPTORS, VIRUS; RNA, MESSENGER; URINARY BLADDER NEOPLASMS;

EID: 33748989559     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-4672     Document Type: Article

References (22)

1. Hall MC, Li Y, Pong RC, et al. The growth inhibitory effect of p21 adenovirus on human bladder cancer cells. J Urol 2000;163:1033-8.
2. Brandau S, Bohle A. Bladder cancer. I. Molecular and genetic basis of carcinogenesis. Eur Urol 2001;39:491-7.
3. Li D, Duan L, Freimuth P, et al. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin Cancer Res 1999;5:4175-81.
4. Hemmi S, Geertsen R, Mezzacasa A, et al. The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum Gene Ther 1998;9:2363-73.
5. Li Y, Pong RC, Bergelson JM, et al. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res 1999;59:325-30.
6. Okegawa T, Pong RC, Li Y, et al. The mechanism of growth inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of CAR protein structure. Cancer Res 2001;61: 6592-600.
7. Okegawa T, Li Y, Pong RC, et al. The dual impact of coxsackie and adenovirus receptor (CAR) expression on human prostate cancer gene therapy. Cancer Res 2000; 60:5031-6.
8. Matsumoto K, Shariat SF, Ayala GE, et al. Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer. Urology 2005;66:441-6.
9. v and coxsackie adenovirus receptor expression in clinical bladder cancer. Urology 2002; 60:531-6.
10. Pong RC, Lai YJ, Chen H, et al. Epigenetic regulation of Coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cells. Cancer Res 2003; 63:8680-6.
11. Okegawa T, Nutahara K, Pong RC, et al. Enhanced transgene expression in urothelial cancer gene therapy with histone deacetylase inhibitor. J Urol 2005;174: 747-52.
12. Tseng CP, Ely BD, Li Y, et al. Regulation of the DOC-2 gene during castration-induced rat ventral prostate degeneration and its growth inhibitory function in human prostatic carcinoma cells. Endocrinology 1998; 139:3542-53.
13. Lai YJ, Pong RC, McConnell JD, et al. Surrogate marker for predicting the virus binding of urogenital cancer cells during adenovirus-based gene therapy. Biotechniques 2003;35:186-94.
14. Gleave ME, Hsieh J-T, Gao CA, et al. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res 1991;51:3753-61.
15. Theodorescu D, Laderoute KR, Calaoagan JM, et al. Inhibition of human bladder cancer cell motility by genistein is dependent on epidermal growth factor receptor but not p21ras gene expression. Int J Cancer 1998;78:775-82.
16. Li C, Teng RH, Tsai YC, et al. H-Ras oncogene counteracts the growth-inhibitory effect of genistein in T24 bladder carcinoma cells. Br J Cancer 2005;92:80-8.
17. Su SJ, Yeh TM, Lei HY, et al. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Clin Cancer Res 2000;6:230-6.
18. Douglas JT, Kim M, Sumerel LA, et al. Efficient oncolysis by a replicating adenovirus (Ad) in vivo is critically dependent on tumor expression of primary Ad receptors. Cancer Res 2001;61:813-7.
19. Rauen KA, Sudilovsky D, Le JL, et al. Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res 2002;62: 3812-8.
20. Fang MZ, Chen D, Sun Y, et al. Reversal of hypermethylation and reactivation of p16INK4a, RARβ, and MGMT genes by genistein and other isoflavones from soy. Reversal of hypermethylation and reactivation of p16-INK4a, RARβ, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 2005;11:7033-41.
21. Dixon RA, Ferreira D. Genistein. Phytochemistry 2002;60:205-11.
22. Zhou JR, Mukherjee P, Gugger ET, et al. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res 1998;58:5231-8.